Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Placebo of Feireqing Granules

Preclinical

HHenan University of Traditional Chinese Medicine

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Severe PneumoniaRecruiting

Severe PneumoniaPreclinical

Recruiting

Timeline

Expected Milestones

Q4 2027

PreclinicalRecruiting

Severe Pneumonia

NCT07206745

Clinical

Trials by Indication[1]

Severe Pneumonia1 trial

Efficacy Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections: A Randomized, Double-Blind, Placebo-Controlled Trial

Recruiting·HHenan University of Traditional Chinese Medicine·Preclinical·NCT07206745·152 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Placebo of Feireqing Granules. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Placebo of Feireqing Granules. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Henan University of Traditional Chinese Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: HHenan University of Traditional Chinese Medicine

Related News